+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Sodium Oxybate Oral Medications Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084840
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Sodium Oxybate Oral Medications Market is projected to reach USD 1.84 Billion in 2026. It is expected to continue growing at a CAGR of 7.80%, reaching USD 2.88 Billion by 2032.

Sodium Oxybate Oral Medications: Executive Overview

Sodium oxybate oral medications are prescription therapies used primarily in the management of narcolepsy-related symptoms, including cataplexy and excessive daytime sleepiness. Their clinical value is linked to the ability to consolidate nighttime sleep and address multiple symptom domains through a controlled dosing schedule. Market development is shaped by diagnosis rates, specialist prescribing, patient adherence, safety controls, reimbursement, and the availability of alternative narcolepsy treatments.

Care Delivery Is Shifting Toward Controlled, Patient-Centered Treatment

The treatment landscape is moving toward earlier recognition of narcolepsy, more structured sleep-medicine pathways, and closer coordination among neurologists, sleep specialists, pharmacists, and primary-care providers. Because sodium oxybate requires careful titration, nighttime administration, counseling, and monitoring for misuse or interaction risks, access increasingly depends on specialized dispensing and risk-management processes. Digital reminders, telehealth follow-up, caregiver education, and standardized adherence support are helping address the practical challenges of treatment.

Artificial Intelligence Strengthens Diagnosis, Monitoring, and Safety

Artificial intelligence can support the sodium oxybate treatment pathway by identifying patterns in sleep diaries, wearable data, clinical notes, and referral records that may warrant specialist assessment. Predictive tools may also help clinicians monitor adherence, detect changes in symptom control, and prioritize follow-up. These applications require rigorous validation because narcolepsy is uncommon, symptoms overlap with other disorders, and treatment decisions must remain clinically supervised. Privacy, explainability, bias control, and secure handling of sensitive sleep and medication data are essential.

Regional Differences Center on Diagnosis, Regulation, and Specialist Access

North America generally benefits from established sleep-medicine infrastructure and structured prescription controls, while access can vary with insurance authorization and specialist availability. Europe is influenced by national reimbursement systems, European Union regulatory coordination, and differences among country-level clinical pathways. Asia-Pacific combines advanced specialist capacity in markets such as Australia, Japan, and South Korea with uneven access across developing systems. Latin America faces disparities in diagnosis, reimbursement, and controlled-medicine distribution. The Middle East shows concentrated specialist services in some health systems, particularly within the GCC, while access across Africa remains closely tied to tertiary-care capacity, regulatory resources, and medicine availability.

Economic and Security Groupings Reveal Uneven Treatment Environments

ASEAN economies reflect substantial variation in sleep-specialist coverage, regulatory maturity, and reimbursement, making regional harmonization difficult. BRICS members span highly diverse healthcare systems and controlled-medicine policies, with access often concentrated in major urban centers. European Union members operate within shared regulatory structures but retain distinct reimbursement and service-delivery models. G7 countries typically have stronger specialist networks and pharmacovigilance capabilities, although affordability and authorization requirements remain relevant. GCC states can offer advanced hospital-based care but differ in procurement and referral arrangements, while NATO membership does not imply uniform narcolepsy treatment access or prescribing policy.

Country-Level Priorities Range from Specialist Expansion to Reimbursement Reform

Australia combines organized healthcare delivery with geographic access challenges, particularly outside major centers. Brazil and Mexico continue to face differences between urban specialist access and broader population needs. Canada and the United States have established sleep-medicine services, with coverage, prior authorization, and controlled-dispensing requirements influencing access. China and India show expanding specialist capacity alongside substantial regional variation. France, Germany, Italy, and Spain operate within mature European frameworks but differ in reimbursement and referral practices. Japan and South Korea have advanced clinical infrastructure with distinct prescribing and monitoring conventions. Russia and the United Kingdom face their own regulatory, procurement, and service-delivery considerations, making locally tailored implementation important.

Industry Leaders Should Prioritize Safe Access and Evidence-Based Support

Leaders should strengthen partnerships with sleep specialists, pharmacies, payers, and patient organizations to simplify appropriate access without weakening safety controls. Treatment programs should provide clear titration guidance, interaction counseling, nighttime dosing support, adherence tools, and rapid pathways for adverse-event reporting. Evidence generation should include real-world adherence, quality-of-life outcomes, health-system burden, and patient-reported functioning across diverse populations. Regional strategies should reflect local regulation and reimbursement, while digital and AI-enabled services should be introduced only with clinical validation, cybersecurity safeguards, and transparent governance.

Methodology: Structured Synthesis of Clinical and Health-System Evidence

This executive summary uses a qualitative evidence-synthesis approach focused on the clinical role of sodium oxybate oral medications and the factors shaping access and use. The assessment considers treatment pathways, prescribing safeguards, adherence requirements, reimbursement conditions, specialist capacity, regulatory context, and regional healthcare differences. Geographic interpretation is organized across the specified regions, groups, and countries. No market estimates, market sizing, market shares, forecasts, or company-specific claims are included; conclusions are framed as evidence-based system and implementation insights.

Conclusion: Responsible Access Will Define Treatment Progress

Sodium oxybate oral medications occupy an important role in narcolepsy care, but their benefits depend on accurate diagnosis, informed prescribing, reliable supply, patient education, and sustained monitoring. Progress will vary by geography because specialist capacity, reimbursement, controlled-medicine governance, and care coordination remain uneven. The strongest strategies will combine rigorous safety management with practical adherence support, locally appropriate access pathways, and carefully validated digital tools that improve continuity of care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sodium Oxybate Oral Medications Market, by Indication
7.1. Introduction
7.2. Idiopathic Hypersomnia
7.3. Narcolepsy
7.3.1. Type One Narcolepsy
7.3.2. Type Two Narcolepsy
8. Sodium Oxybate Oral Medications Market, by Strength
8.1. Introduction
8.2. Four Point Five Gram
8.3. Nine Gram
8.4. Seven Point Five Gram
8.5. Six Gram
9. Sodium Oxybate Oral Medications Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
9.5. Specialty Pharmacies
10. Sodium Oxybate Oral Medications Market, by Dosage Form
10.1. Introduction
10.2. Liquid
10.3. Powder
11. Sodium Oxybate Oral Medications Market, by End User
11.1. Introduction
11.2. Home Care
11.3. Hospitals
11.4. Specialty Clinics
12. Sodium Oxybate Oral Medications Market, by Packaging Type
12.1. Introduction
12.2. Multi Dose
12.3. Single Dose
13. Sodium Oxybate Oral Medications Market, by Patient Age Group
13.1. Introduction
13.2. Adults
13.3. Pediatrics
14. Sodium Oxybate Oral Medications Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Sodium Oxybate Oral Medications Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Sodium Oxybate Oral Medications Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. Alembic Pharmaceuticals Limited
18.2. Amneal Pharmaceuticals, Inc.
18.3. Aurobindo Pharma Limited
18.4. Cipla Limited
18.5. Dr. Reddy's Laboratories Ltd.
18.6. Glenmark Pharmaceuticals Ltd.
18.7. Hetero Labs Limited
18.8. Hikma Pharmaceuticals PLC
18.9. Jazz Pharmaceuticals plc
18.10. Lannett Company, Inc.
18.11. Lupin Limited
18.12. Macleods Pharmaceuticals Ltd.
18.13. Mylan N.V.
18.14. Natco Pharma Limited
18.15. Novartis AG
18.16. Strides Pharma Science Limited
18.17. Sun Pharmaceutical Industries Ltd.
18.18. Teva Pharmaceutical Industries Ltd.
18.19. Torrent Pharmaceuticals Ltd.
18.20. Zydus Lifesciences Limited
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Sodium Oxybate Oral Medications Market, Years Considered for the Study
FIGURE 2. Global Sodium Oxybate Oral Medications Market, Research Design
FIGURE 3. Global Sodium Oxybate Oral Medications Market, Research Framework
FIGURE 4. Global Sodium Oxybate Oral Medications Market, Data Triangulation
FIGURE 5. Global Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Sodium Oxybate Oral Medications Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Sodium Oxybate Oral Medications Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Sodium Oxybate Oral Medications Market Size, by Strength, 2025 vs 2032 (%)
FIGURE 9. Global Sodium Oxybate Oral Medications Market Size, by Strength, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 13. Global Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Sodium Oxybate Oral Medications Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Sodium Oxybate Oral Medications Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2025 vs 2032 (%)
FIGURE 17. Global Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2025 vs 2032 (%)
FIGURE 19. Global Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Sodium Oxybate Oral Medications Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Sodium Oxybate Oral Medications Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Sodium Oxybate Oral Medications Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Sodium Oxybate Oral Medications Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Sodium Oxybate Oral Medications Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Sodium Oxybate Oral Medications Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Sodium Oxybate Oral Medications Market Segmentation & Coverage
TABLE 2. Global Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 3. Global Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Idiopathic Hypersomnia Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Idiopathic Hypersomnia Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Idiopathic Hypersomnia Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Narcolepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Narcolepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Narcolepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Type One Narcolepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Type One Narcolepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Type One Narcolepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Type Two Narcolepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Type Two Narcolepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Type Two Narcolepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 17. Global Four Point Five Gram Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Four Point Five Gram Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Four Point Five Gram Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Nine Gram Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Nine Gram Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Nine Gram Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Seven Point Five Gram Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Seven Point Five Gram Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Seven Point Five Gram Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Six Gram Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Six Gram Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Six Gram Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 30. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Specialty Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Specialty Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Specialty Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 43. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 50. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 60. Global Multi Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Multi Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Multi Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Single Dose Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Single Dose Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Single Dose Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 67. Global Adults Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Adults Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Adults Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Pediatrics Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Pediatrics Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Pediatrics Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 83. North America Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. North America Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 85. North America Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 86. North America Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 87. North America Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 88. North America Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 89. North America Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. North America Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 91. North America Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 92. Latin America Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Latin America Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 94. Latin America Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 95. Latin America Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 96. Latin America Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 97. Latin America Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 98. Latin America Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Latin America Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 100. Latin America Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 101. Europe Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Europe Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 103. Europe Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 104. Europe Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 105. Europe Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 106. Europe Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 107. Europe Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Europe Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 109. Europe Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 110. Middle East Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Middle East Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 112. Middle East Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 113. Middle East Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 114. Middle East Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Middle East Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 116. Middle East Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Middle East Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 118. Middle East Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 119. Africa Sodium Oxybate Oral Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Africa Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 121. Africa Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 122. Africa Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 123. Africa Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 124. Africa Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 125. Africa Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Africa Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 127. Africa Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 128. Global Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. ASEAN Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. ASEAN Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 131. ASEAN Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 132. ASEAN Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 133. ASEAN Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. ASEAN Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 135. ASEAN Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. ASEAN Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 137. ASEAN Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 138. GCC Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. GCC Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 140. GCC Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 141. GCC Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 142. GCC Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. GCC Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 144. GCC Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. GCC Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 146. GCC Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 147. European Union Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. European Union Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 149. European Union Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 150. European Union Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 151. European Union Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. European Union Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 153. European Union Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. European Union Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 155. European Union Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 156. BRICS Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. BRICS Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 158. BRICS Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 159. BRICS Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 160. BRICS Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. BRICS Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 162. BRICS Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. BRICS Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 164. BRICS Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 165. G7 Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. G7 Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 167. G7 Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 168. G7 Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 169. G7 Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 170. G7 Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 171. G7 Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. G7 Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 173. G7 Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 174. NATO Sodium Oxybate Oral Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. NATO Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 176. NATO Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 177. NATO Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 178. NATO Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. NATO Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 180. NATO Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. NATO Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 182. NATO Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 183. Global Sodium Oxybate Oral Medications Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. United States Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 185. United States Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 186. United States Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 187. United States Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 188. United States Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. United States Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 190. United States Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. United States Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 192. United States Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 193. Canada Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 194. Canada Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 195. Canada Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 196. Canada Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 197. Canada Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 198. Canada Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 199. Canada Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Canada Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 201. Canada Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 202. Mexico Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 203. Mexico Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 204. Mexico Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 205. Mexico Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 206. Mexico Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Mexico Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 208. Mexico Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Mexico Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 210. Mexico Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 211. Brazil Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 212. Brazil Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 213. Brazil Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 214. Brazil Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 215. Brazil Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 216. Brazil Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 217. Brazil Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Brazil Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 219. Brazil Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 220. United Kingdom Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 221. United Kingdom Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. United Kingdom Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 223. United Kingdom Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 224. United Kingdom Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 225. United Kingdom Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 226. United Kingdom Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. United Kingdom Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 228. United Kingdom Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 229. Germany Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 230. Germany Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 231. Germany Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 232. Germany Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 233. Germany Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 234. Germany Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 235. Germany Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Germany Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 237. Germany Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 238. France Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 239. France Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 240. France Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 241. France Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 242. France Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. France Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 244. France Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. France Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 246. France Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 247. Russia Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 248. Russia Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 249. Russia Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 250. Russia Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 251. Russia Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 252. Russia Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 253. Russia Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Russia Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 255. Russia Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 256. Italy Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 257. Italy Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 258. Italy Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 259. Italy Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 260. Italy Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Italy Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 262. Italy Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Italy Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 264. Italy Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 265. Spain Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 266. Spain Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 267. Spain Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 268. Spain Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 269. Spain Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 270. Spain Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 271. Spain Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Spain Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 273. Spain Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 274. China Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 275. China Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 276. China Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 277. China Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 278. China Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 279. China Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 280. China Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. China Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 282. China Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 283. India Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 284. India Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 285. India Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 286. India Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 287. India Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 288. India Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 289. India Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. India Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 291. India Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 292. Japan Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 293. Japan Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 294. Japan Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 295. Japan Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 296. Japan Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 297. Japan Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 298. Japan Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Japan Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 300. Japan Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 301. Australia Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 302. Australia Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 303. Australia Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 304. Australia Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 305. Australia Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 306. Australia Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 307. Australia Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Australia Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 309. Australia Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 310. South Korea Sodium Oxybate Oral Medications Market Size, 2017-2032 (USD Million)
TABLE 311. South Korea Sodium Oxybate Oral Medications Market Size, by Indication, 2017-2032 (USD Million)
TABLE 312. South Korea Sodium Oxybate Oral Medications Market Size, by Narcolepsy, 2017-2032 (USD Million)
TABLE 313. South Korea Sodium Oxybate Oral Medications Market Size, by Strength, 2017-2032 (USD Million)
TABLE 314. South Korea Sodium Oxybate Oral Medications Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 315. South Korea Sodium Oxybate Oral Medications Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 316. South Korea Sodium Oxybate Oral Medications Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. South Korea Sodium Oxybate Oral Medications Market Size, by Packaging Type, 2017-2032 (USD Million)
TABLE 318. South Korea Sodium Oxybate Oral Medications Market Size, by Patient Age Group, 2017-2032 (USD Million)
TABLE 319. Global Sodium Oxybate Oral Medications Market Share, by Key Player, 2025
TABLE 320. Global Sodium Oxybate Oral Medications Market, Key Experts

Companies Mentioned

  • Alembic Pharmaceuticals Limited
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Hetero Labs Limited
  • Hikma Pharmaceuticals PLC
  • Jazz Pharmaceuticals plc
  • Lannett Company, Inc.
  • Lupin Limited
  • Macleods Pharmaceuticals Ltd.
  • Mylan N.V.
  • Natco Pharma Limited
  • Novartis AG
  • Strides Pharma Science Limited
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Lifesciences Limited